Search Results - herbert+seltzman

2 Results

Sort By:

2020-426 PRODRUGS OF PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN

Researchers at UCLA have developed prodrugs of peripherally-acting cannabinoid (PRCBs) receptor agonists for chronic pain relief. BACKGROUND: Cannabinoids are becoming prevalent in chronic pain treatments even though current marketed cannabinoid compounds may cause psychotropic effects or central nervous system (CNS)-mediated side effects. A potential...

Published: 9/5/2023 | Inventor(s): Igor Spigelman, Alexander Spokoyny, Herbert Seltzman

Keywords(s): Cns, Drug Delivery, Therapeutics & Vaccines

Category(s): Platforms > Drug Delivery, Therapeutics, Therapeutics > CNS and Neurology

2012-715 Peripherally-Acting Cannabinoid Receptor Agonists for Chronic Pain

Peripherally-Acting Cannabinoid Receptor Agonists for Chronic PainSUMMARYResearchers from UCLA and RTI International have developed novel, small molecule agonists at cannabinoid type 1 and type 2 receptors (CB1R and CB2R) that have low blood-brain barrier (BBB) permeability. The compounds represent promising therapeutics for treating chronic pain....

Published: 7/19/2023 | Inventor(s): Igor Spigelman, Craig Shiner, Herbert Seltzman

Keywords(s): Anesthesiology, Cns, Therapeutics & Vaccines

Category(s): Therapeutics, Therapeutics > CNS and Neurology, Therapeutics > Critical Care > Anesthesiology